ArticleBMC cancer2019

Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.

Edith A Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.